X
  • Boya Bio-pharmaceutical
    http://www.china-boya.com/
    Boya Bio-pharmaceutical
    Established in 1993, Boya is a high-tech pharmaceutical enterprise centered on blood products business, aiming to be the biggest enterprise producing monosomic blood products and a world-class blood products enterprise. Boya gained the strategic holding investment by GIG in 2007, and successfully went public on Growth Enterprise Market(stock code: 300294) in 2012
    /uploads/allimg/171212/1_121213450J1Y.jpg
  • SINOMD
    http://sinomdgene.com/
    SINOMD
    Established in 2008, Sinomd is the developer of clinical application of gene detection, and a gene detecting enterprise with innovative advantages in products for Whole course of tumor, Pharmacogenomics and Detection of pathogenic microorganism, that gained a strategic investment by GIG in 2013.
    /uploads/allimg/171212/1_12121345062H1.jpg
  • Mindray Bio-medical
    http://www.mindray.com/cn/
    Mindray Bio-medical
    Established in 1991, Mindray is a leading supplier for medical equipments and solutions, which went public in NYSE in 2006 and was delisted in the beginning of 2016. Mindray gained the investment in Pre-IPO from GIG in November, 2016 and submitted IPO materials to A-shares in May, 2017.
    /uploads/allimg/171212/1_12121345061315.jpg
  • Annoroad
    http://www.annoroad.com/
    Annoroad
    Established in 2012, Annoroad is the most notable star enterprise of high-throughput sequencing, aiming to be an advanced eco-enterprise in gene industry, strategically invested by GIG respectively in Round B in 2015 and Round C in 2017.
    /uploads/allimg/171212/1_121213450522O.jpg
  • Harmony Diagnostics
    http://www.labhh.com/
    Harmony Diagnostics
    Established in 2010, Harmony Diagnostics is the biggest domestic medical inspection company featured with mass spectrum/color spectrum, aiming to be a leading domestic brand in the field of high-end medical inspection, Round C invested in 2015 by GIG as the leading investor.
    /uploads/allimg/171212/1_1212134504G45.jpg
  • ZJ Bio-tech
    http://www.liferiver.com.cn/
    ZJ Bio-tech
    Established in 2005, ZJ Bio-tech is a domestic leading enterprise in the producing of molecule diagnosing reagent, which is also laying out for subsidiary fields of IVD, Pre-IPO invested in April, 2017 by GIG as the leading investor.
    /uploads/allimg/171212/1_1212134503V57.jpg
  • ZHITONGSHENGWU
    http://www.zhitongshengwu.com/
    ZHITONGSHENGWU
    Established in 1993, ZHITONGSHENGWU has set the goal of building an internationally first-class integrated industrial base of ICH bio-chemical materials and preparation, Pre-IPO invested in December, 2015 by GIG.
    /uploads/allimg/171212/1_12121345024162.jpg
  • HUAYIN HEALTH
    http://www.huayinlab.com/
    HUAYIN HEALTH
    Established in 2009, HUAYIN is the largest third-party inspection service company in domestic long-distance pathological diagnosing, with the core capacity of medical diagnostic technology and service to provide all-round solutions for medical organizations, aiming to be a worldwide first-class medical service enterprise. HUAYIN gained the investment in Round B in May, 2017 by GIG as the leading investor.
    /uploads/allimg/171212/1_12121345012557.jpg
  • Mabworks
    http://www.mab-works.com/
    Mabworks
    Established in 2003, Mabworks holds a strong capacity of researching and developing monoclonal antibody-based medicine and industrial technology, and has formed a well rounded technology system, aiming to be a bio-pharmaceutical enterprise with core products and sustainable innovative ability, both Round A in 2016 and Round B in 2017 invested by GIG as the leading investors.
    /uploads/allimg/171212/1_121213450124J.jpg
  • Righton
    http://www.rightongene.com/
    Righton
    Established in 2012, Righton is now the leading company in domestic leukemia molecule diagnosing market, running the main business of researching, producing and selling of blood products and accurate molecule diagnosing products for solid tumors while providing relative inspecting service, Round B invested by GIG in December, 2016.
    /uploads/allimg/171212/1_1212134500JL.jpg
  • Biohealthcare Biotechnology
    http://biohealthcare.com.cn/
    Biohealthcare Biotechnology
    Established in 2012, Biohealthcare runs the main business of cell immune treating and third-party medical inspecting, aiming to be a leading enterprise of cell immune treating. Biohealthcare went public in the New OTC Market on Jul.28th, 2015, strategically invested by GIG in 2017.
    /uploads/allimg/171212/1_12121345005W4.jpg
  • Vivachek
    http://www.vivachek.com.cn/
    Vivachek
    Established in 2013, Vivachek is a rising star in the field of blood sugar inspection, aiming to be a globally leading company in segmented industries of POCT.
    /uploads/allimg/171212/1_1212134500c06.jpg
  • Danxia
    http://www.danxia-biopharm.com
    Danxia
    Established in 2008, Danxia is a producing enterprise of professional research and developing, producing and sale of blood products, with a capacity of handling 400 tons of blood, aiming to be a domestically first-class blood products enterprise, strategically mergered by GIG in March, 2017.
    /uploads/allimg/171212/1_12121344593063.jpg
  • ZHONGYIJIA
    http://www.zhongyijia.com.cn/
    ZHONGYIJIA
    Established in 2015, ZHONGYIJIA is devoted to build an alliance of Chinese traditional doctors, offering a platform of social activities, industry information, academic communication, continuing major education and work information by establishing and operating a Chinese traditional doctors’ community, invested by GIG in January, 2017.
    /uploads/allimg/171212/1_121213445c2N.jpg
  • Bioscience
    http://www.bioscience-tj.com/
    Bioscience
    Established in 2010, Bioscience is a giant enterprise on in vitro diagnosis featured with chemiluminescence, aiming to be a leading supplier of in vitro diagnosis products in Asia, strategically invested by GIG in Round A in 2014 and Round A+ in 2015.
    /uploads/allimg/171212/1_121213445Q519.jpg
  • XINBAI PHARMACEUTICAL
    http://www.njxbyy.com/
    XINBAI PHARMACEUTICAL
    Established in 2001, XINBAI has been focusing on the developing and popularizing of elite domestically produced bio-medication, with the goal of building a groupized enterprise, aiming to be a large integrated pharmaceutical group company of research and developing, producing and sale in the field of medicine and healthcare products producing and selling, changed to be a subsidiary company of Boya Bio-pharmaceutical in 2015.
    /uploads/allimg/171212/1_121213445W5K.jpg
  • Sansure Biotech
    http://www.sansure.com.cn/
    Sansure Biotech
    Established in 2008, with the core of gene detecting technology, Sansure is an integrated whole solution supplier of diagnosing reagent, apparatus researching and developing, producing, selling and technology service together with third-party medical inspection service. Sansure is now one of the leading enterprises with the most advanced technology and the most complete product line in domestic gene detecting industry, invested by GIG in August, 2017.
    /uploads/allimg/171212/1_121213445RR8.jpg
  • American-Sino
    http://www.am-sino.com/
    American-Sino
    Established in 2002, American-Sino has been dedicated to providing high-end medical service to social elites, with the effort to build a centenary brand in Chinese medical service for women and children, Round B invested in November, 2016 by GIG as the leading investors.
    /uploads/allimg/171212/1_121213445I552.jpg
  • Tian’an Pharmaceutical
    http://www.itianan.com/
    Tian’an Pharmaceutical
    Established in 2002, Tian’an is a professional integrated pharmaceutical enterprise of research and developing, producing and sale of diabetic medication, aiming to be the best enterprise of diabetic pharmaceutical and healthcare, strategically purchased by Boya Bio-pharmaceutical in August, 2015.
    /uploads/allimg/171212/1_121213445NO7.jpg
  • ENDISHENGWU
    http://www.scisoon.cn/
    ENDISHENGWU
    Established in 2011, ENDISHENGWU owns a worldly first-class sequencing platform and laboratory researching and developing team of biological information analyzing, among the first that gained support from the country in the thirteenth Five-Year Plan in the field of birth defect inspection, and the only enterprise that simultaneously possesses the technology platforms of CTC and ctDNA in the field of tumor liquid biopsy, having a national marketing network to increase achievements fast. ENDISHENGWU gained the investment from GIG in Round A in July, 2017.
    /uploads/allimg/171212/1_121213445N529.jpg
  • Akesobio
    http://www.akesobio.com/
    Akesobio
    Established in 2012, Akesobio has been dedicated to developing innovative antibody medicine with independent intellectual property right, aiming to be an international first-class enterprise of innovative antibody medication, Round B invested in 2017 by GIG as the leading investor.
    /uploads/allimg/171212/1_121213445EO2.jpg
  • BASDA
    http://www.basda.com.cn/
    BASDA
    Established in 2000, BASDA is an integrated professional manufacturer of researching and developing, manufacturing, selling and service of high-end medical imaging and radiation therapy products, which went public in the New OTC Market on Sep.29th, 2015, with efforts to make a leading and internationally famous brand. BASDA gained the investment in 2010 by GIG as the leading investor.
    /uploads/allimg/171212/1_121213445D100.jpg
  • DUOPUTAI
    http://www.jobuy.com/vipjob/du
    DUOPUTAI
    Established in 2004, DUOPUTAI is mainly on the researching and developing, producing and selling of Chinese Traditional Patent Medicine, devoted to build an integrated Big Health industry of Chinese traditional medicine growing and cultivating, researching and developing, producing, selling and corresponding service, making itself a leading enterprise with big growing space, sustainable profiting ability and strong innovative capacity. DUOPUTAI gained the investment in Round A from GIG in November, 2012.
    /uploads/allimg/171212/1_12121344561611.jpg
  • SINOPATHO
    http://www.sinopatho.com/
    SINOPATHO
    Established in 2007, SINOPATHO is a trust-worthy accurate diagnosing expert, building a one-stop solution with the core of pathological diagnosis, which is provided together with molecule diagnosis for tumor patients and relative medical organizations, Round A invested by GIG in November, 2016.
    /uploads/allimg/171212/1_12121344551525.jpg
  • BIOVALLEY
    http://www.biovalley.cn/
    BIOVALLEY
    Established in 1999, BIOVALLEY went public in the New OTC Market in August, 2015. Devoted to prophylaxis and treatment of cardio-cerebrovascular disease, BIOVALLEY is an integrated professional high-tech pharmaceutical enterprise of researching, developing, producing and selling of medicine of herba erigerontis series, aiming to be a leading enterprise of chronic diseases treating with superior botanical resources, Pre-IPO invested by GIG in July, 2016.
    /uploads/allimg/171212/1_12121344559242.jpg
  • GYT TRADITIONAL CHINESE MEDICINE
    http://www.ahgyt.cn/
    GYT TRADITIONAL CHINESE MEDICINE
    Established in 2010, GYT is a large integrated modernized enterprise of medicine manufacturing, botanical extracting, preparation developing and healthcare food and drinks manufacturing as well as export trading, with efforts to build a famous brand home and abroad of Chinese traditional medicine and healthcare products. GYT gained the investments by GIG in 2011 and 2014.
    /uploads/allimg/171212/1_12121344542644.jpg
  • ASK e-health
    http://www.ask-app.com/
    ASK e-health
    Established in 2014, ASK has assisted departments in out-of-hospital chronic disease management, aiming to be the leading enterprise in China’s commercial health insurance, Round A invested by GIG in 2016.
    /uploads/allimg/171212/1_12121344545354.jpg
  • iHealth Finance
    https://www.ajk.com/
    iHealth Finance
    Established in 2015, AJK is a forerunner of online financial platforms in domestic investing, seeking elite subjects of creditor’s right in the four phases of equity investment, which are fund raising, investing, managing and quitting, so as to create risk-controllable and return-remarkable chances of creditor’s right investment for investors with its professional and stable value investing philosophy as well as the reasonable and safe transaction design. AJK aims to be the most excellent online financial platform in the field of Big Health.
    /uploads/allimg/171212/1_12121344543053.jpg
  • CHENGFENG PHARMACEUTICAL
    http://www.huiyinbi.com/
    CHENGFENG PHARMACEUTICAL
    Established in 2006, CHENGFENG is now holding HUIYINBI GROUP, focusing on infusion and oral preparation of medium and chemical medicine, with efforts to make the most potential and innovative enterprise in medical industry, invested in 2014 and 2016 by GIG as the leading investor.
    /uploads/allimg/171212/1_121213445392b.jpg
  • BODYYOUNG
    http://www.bodyyoung.cn/
    BODYYOUNG
    Established in 2013, BODYYOUNG is the forerunner in domestic high-end recovery medication as well as the first international high-end recovery medical center based on new reorganized medication, started with Chiropractic, combined with international cutting-edge technology of exercising recovery and physical treating technology along with the essence of Chinese and Western medication. BODYYOUNG gained the investment in November, 2016 by GIG as the leading investor.
    /uploads/allimg/171212/1_1212134453AN.jpg
  • PINGGUANG PHARMACEUTICAL
    http://www.pgzyjt.com/
    PINGGUANG PHARMACEUTICAL
    Established in 2001, PINGGUANG is a large pharmaceutical group enterprise of products involving the fields of Chinese Traditional Patent Medicine and Western Medicine, invested in 2013 by GIG as the leading investor.
    /uploads/allimg/171212/1_12121344534c7.jpg
  • MEBEL
    http://www.0512mebel.com/?pz
    MEBEL
    Established in July 2012, MEBEL is a chain organization providing medical aesthetic service, aiming to be a leading enterprise in medical aesthetic industry, strategically invested by GIG in January, 2017.
    /uploads/allimg/171212/1_1212134452SG.jpg
  • Sunho Pharmaceutical
    http://www.wellem.com/cn
    Sunho Pharmaceutical
    Established in 2000, Sunho mainly runs the business of medicine products researching and developing, manufacturing and selling, aiming to be the most creative manufacturer of international high-end unpatented medicine. Sunho gained the investment from GIG in Round B in May, 2015.
    /uploads/allimg/171212/1_12121344519518.jpg
  • VANGUARD PHARMACEUTICAL
    http://www.wangao.com.cn/
    VANGUARD PHARMACEUTICAL
    Established in 2003, VANGUARD is a modernized pharmaceutical manufacturing enterprise of chemical medicine and Chinese Traditional Patent Medicine developing, covering cardio-cerebrovascular medicine, diabetic medicine, anti-tumor medicine and hemostatic and analgesic medicine, aiming to be a leading enterprise in special medicine industry of chronic cardio-cerebrovascular disease and anti-tumor treating. VANGUARD gained the investment from GIG in 2013.
    /uploads/allimg/171212/1_12121344511C6.jpg
  • WELLEM
    http://www.wellem.com/cn
    WELLEM
    Established in 2015, WELLEM is the first US-originated private pediatric clinic, bringing in the advanced medical and managing philosophy from America by double-brand operating with Sunray Clinic, aiming to be the first brand of domestic medium/high-end pediatric chain clinics, Round A invested in April, 2017 by GIG as the leading investor.
    /uploads/allimg/171212/1_1212134451F59.jpg
  • SHE SAYS
    http://www.xichan.cn/
    SHE SAYS
    Established in 2005, SHE SAYS is a special chain hospital for plastic surgery and aesthetic jointly founded by domestically famous plastic surgery experts, aesthetic and skincare experts and stomatological experts, now ranking ahead in domestic medical aesthetic industry as one of the most powerful and influential medical aesthetic organizations in the southwest. SHE SAYS gained the strategic investment in August, 2017 from GIG.
    /uploads/allimg/171212/1_121213445033X.jpg
  • LBP (Linked Biotech Pathology)
    http://www.gzlbp.com/
    LBP (Linked Biotech Pathology)
    Established in 2005, LBP focuses on the producing and service of pathological diagnosing products, aiming to be a leading company in domestic pathological diagnosing products industry so as to better share the value of growing with partners, invested in August, 2017 by GIG.
    /uploads/allimg/171212/1_1212134450O26.jpg